Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Dunsire Deborah, Director. Insider active across 4 companies, notably ALEXION PHARMACEUTICALS, INC.. In total, 9 filings have been recorded. History available since 20 May 2021. The latest transaction was filed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Deborah Dunsire is a board member at Alexion Pharmaceuticals, Inc. and Ultragenyx Pharmaceutical Inc. She brings her expertise in biopharmaceuticals to guide strategic decisions and ensure the growth of the companies.